3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2024年3月31日) | 当連結会計年度 (2025年3月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 29,650 | 45,471 |
受取手形及び売掛金 | 62,916 | 61,449 |
電子記録債権 | 8,854 | 10,496 |
商品及び製品 | 48,986 | 44,770 |
仕掛品 | 13,906 | 18,648 |
原材料及び貯蔵品 | 38,180 | 44,869 |
デリバティブ債権 | 9,531 | 10,791 |
その他 | 5,804 | 11,123 |
貸倒引当金 | △113 | △314 |
流動資産合計 | 217,718 | 247,306 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物(純額) | 57,219 | 76,073 |
機械装置及び運搬具(純額) | 18,017 | 18,367 |
土地 | 18,251 | 18,259 |
リース資産(純額) | 848 | 11,802 |
建設仮勘定 | 55,917 | 40,089 |
その他(純額) | 3,389 | 3,830 |
有形固定資産合計 | 153,642 | 168,423 |
無形固定資産 | | |
のれん | 32,568 | 28,115 |
製造販売権 | 6,873 | 7,473 |
技術関連資産 | 6,302 | 5,489 |
その他 | 4,841 | 4,764 |
無形固定資産合計 | 50,586 | 45,842 |
投資その他の資産 | | |
投資有価証券 | 641 | 871 |
関係会社株式 | 607 | 506 |
繰延税金資産 | 5,699 | 6,037 |
その他 | 2,557 | 2,684 |
貸倒引当金 | △800 | △848 |
投資その他の資産合計 | 8,705 | 9,250 |
固定資産合計 | 212,934 | 223,517 |
資産合計 | 430,653 | 470,823 |
| | (単位:百万円) |
| 前連結会計年度 (2024年3月31日) | 当連結会計年度 (2025年3月31日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 15,652 | 17,918 |
電子記録債務 | 10,720 | 12,123 |
短期借入金 | 3,112 | 4,699 |
1年内返済予定の長期借入金 | 10,120 | 18,023 |
リース債務 | 238 | 1,383 |
未払金 | 15,985 | 15,482 |
未払法人税等 | 7,926 | 4,852 |
役員賞与引当金 | 96 | 112 |
設備関係支払手形 | 3,815 | 5,358 |
設備関係未払金 | 5,952 | 3,714 |
その他 | 6,495 | 4,270 |
流動負債合計 | 80,118 | 87,939 |
固定負債 | | |
長期借入金 | 189,124 | 195,077 |
リース債務 | 714 | 11,801 |
退職給付に係る負債 | 220 | 141 |
その他 | 4,581 | 4,237 |
固定負債合計 | 194,641 | 211,259 |
負債合計 | 274,759 | 299,198 |
純資産の部 | | |
株主資本 | | |
資本金 | 4,717 | 4,717 |
資本剰余金 | 7,838 | 7,841 |
利益剰余金 | 134,452 | 150,502 |
自己株式 | △5,606 | △5,586 |
株主資本合計 | 141,401 | 157,474 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 191 | 228 |
為替換算調整勘定 | 14,300 | 13,921 |
その他の包括利益累計額合計 | 14,491 | 14,150 |
純資産合計 | 155,893 | 171,625 |
負債純資産合計 | 430,653 | 470,823 |
E0097445530東和薬品株式会社TOWA PHARMACEUTICAL CO., LTD.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2024-04-012025-03-31FY2025-03-312023-04-012024-03-312024-03-311falsefalsefalse455302025-03-31jpcrp_cor:ReportableSegmentsMember455302024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember455302024-03-31jpcrp_cor:ReportableSegmentsMember455302023-04-012024-03-31jpcrp_cor:ReportableSegmentsMember455302025-03-31tse-acedjpfr-45530:DomesticReportableSegmentsMember455302025-03-31tse-acedjpfr-45530:OverseasReportableSegmentsMember455302024-04-012025-03-31tse-acedjpfr-45530:DomesticReportableSegmentsMember455302024-04-012025-03-31tse-acedjpfr-45530:OverseasReportableSegmentsMember455302024-03-31tse-acedjpfr-45530:DomesticReportableSegmentsMember455302024-03-31tse-acedjpfr-45530:OverseasReportableSegmentsMember455302023-04-012024-03-31tse-acedjpfr-45530:DomesticReportableSegmentsMember455302023-04-012024-03-31tse-acedjpfr-45530:OverseasReportableSegmentsMember455302025-03-31jpcrp_cor:ReconcilingItemsMember455302024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember455302024-03-31jpcrp_cor:ReconcilingItemsMember455302023-04-012024-03-31jpcrp_cor:ReconcilingItemsMember455302023-03-31jppfs_cor:CapitalStockMember455302023-03-31jppfs_cor:CapitalSurplusMember455302023-03-31jppfs_cor:RetainedEarningsMember455302023-03-31jppfs_cor:TreasuryStockMember455302023-04-012024-03-31jppfs_cor:CapitalStockMember455302023-04-012024-03-31jppfs_cor:CapitalSurplusMember455302023-04-012024-03-31jppfs_cor:TreasuryStockMember455302023-04-012024-03-31jppfs_cor:ShareholdersEquityMember455302023-04-012024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302024-03-31jppfs_cor:CapitalStockMember455302024-03-31jppfs_cor:CapitalSurplusMember455302024-03-31jppfs_cor:RetainedEarningsMember455302024-03-31jppfs_cor:TreasuryStockMember455302024-03-31jppfs_cor:ShareholdersEquityMember455302024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302023-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302025-05-15455302025-03-31455302024-04-012025-03-31455302024-03-31455302023-03-31455302023-04-012024-03-31455302023-03-31jppfs_cor:ShareholdersEquityMember455302023-04-012024-03-31jppfs_cor:RetainedEarningsMember455302025-03-31jppfs_cor:ShareholdersEquityMember455302025-03-31jppfs_cor:CapitalStockMember455302025-03-31jppfs_cor:CapitalSurplusMember455302025-03-31jppfs_cor:RetainedEarningsMember455302025-03-31jppfs_cor:TreasuryStockMember455302025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302024-04-012025-03-31jppfs_cor:ShareholdersEquityMember455302024-04-012025-03-31jppfs_cor:CapitalStockMember455302024-04-012025-03-31jppfs_cor:CapitalSurplusMember455302024-04-012025-03-31jppfs_cor:RetainedEarningsMember455302024-04-012025-03-31jppfs_cor:TreasuryStockMember455302024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302023-04-012024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302023-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455302024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455302024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455302023-04-012024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455302023-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMemberxbrli:pureiso4217:JPY